RxDoctor Payments Data

Kenneth Alexander

Infectious Disease · Orlando, FLNPI 1962582031

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (51.2%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Merck accounts for 97.6% of it on its own, with 2 other manufacturers making up the rest. Among infectious disease clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$474,019in general payments, 2019–2025

Across 333 payments — averaging $1423.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$463K
  • Biofire Diagnostics, LLC$11K
  • Pfizer$94

What the payments were for

  • Consulting fees$23,1935%
  • Speaking & faculty fees$242,73851%
  • Travel & lodging$203,18243%
  • Food & beverage$4,9061%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck330$462,548
Biofire Diagnostics, LLC2$11,378
Pfizer1$94

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$474,019 in reported general payments places this provider in the 95th percentile of 669 infectious disease providers in Florida.

See all infectious disease providers in Florida

Other infectious disease in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →